1–3 of 3 results for biosimilars
Biosimilar Paradox: How Biosimilar Use Will Increase Patient and Healthcare Costs
Ravi Parikh, MD MPH
Annual Meeting Talks
2023
Intravitreal Therapeutics Utilization in 2023
Anton M Kolomeyer, MD, PhD
2024
Biosimilars: What Can Retina Learn from Oncology?
Kathy W Oubre, MS
Updates from the Field
2022